Performance of EXAS EXACT Sciences | -2.5% in 12m
Compare EXAS with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare EXACT Sciences with its related Sector/Index XBI
Performance Duell EXAS vs XBI
| TimeFrame | EXAS | XBI |
|---|---|---|
| 1 Day | 2.53% | 1.86% |
| 1 Week | 5.47% | 7.77% |
| 1 Month | -14.8% | -1.16% |
| 3 Months | -3.09% | 2.28% |
| 6 Months | -7.39% | 25.94% |
| 12 Months | -2.54% | 8.16% |
| YTD | -15.9% | -0.28% |
| Rel. Perf. 1m | -1.29 | |
| Rel. Perf. 3m | -1.35 | |
| Rel. Perf. 6m | -3.02 | |
| Rel. Perf. 12m | -1.23 |
Is EXACT Sciences a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, EXACT Sciences is currently (May 2024)
neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -16.12 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EXAS as of May 2024 is 52.45. This means that EXAS is currently overvalued and has a potential downside of -15.5% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EXAS as of May 2024 is 52.45. This means that EXAS is currently overvalued and has a potential downside of -15.5% (Sold with Premium).
Is EXAS a buy, sell or hold?
- Strong Buy: 17
- Buy: 3
- Hold: 2
- Sell: 0
- Strong Sell: 0
Values above 0%: EXAS is performing better - Values below 0%: EXAS is underperforming
Compare EXAS with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 4.87% | -13.20% | -25.86% | -29.66% |
| US NASDAQ 100 | QQQ | 4.43% | -13.26% | -26.28% | -40.71% |
| US Dow Jones Industrial 30 | DIA | 4.30% | -13.66% | -22.01% | -20.54% |
| German DAX 40 | DBXD | 6.36% | -12.69% | -25.66% | -15.69% |
| UK FTSE 100 | ISFU | 3.81% | -17.97% | -21.76% | -11.99% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 1.96% | -18.39% | -10.60% | 7.24% |
| Hongkong Hang Seng | HSI | -0.29% | -22.82% | -6.19% | 11.33% |
| Japan Nikkei 225 | EXX7 | 3.12% | -9.95% | -21.01% | -22.95% |
| India NIFTY 50 | INDA | 4.69% | -16.79% | -26.82% | -31.65% |
| Brasil Bovespa | EWZ | 3.03% | -15.45% | -12.27% | -26.80% |
EXAS EXACT Sciences vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 5.35% | -11.62% | -26.73% | -40.81% |
| Consumer Discretionary | XLY | 4.33% | -13.62% | -18.87% | -25.86% |
| Consumer Staples | XLP | 5.09% | -16.57% | -19.42% | -4.42% |
| Energy | XLE | 8.78% | -10.09% | -16.08% | -23.79% |
| Financial | XLF | 6.13% | -12.12% | -28.48% | -31.68% |
| Health Care | XLV | 4.85% | -12.54% | -18.82% | -9.80% |
| Industrial | XLI | 5.38% | -12.94% | -29.26% | -28.49% |
| Materials | XLB | 5.46% | -11.15% | -22.23% | -18.42% |
| Real Estate | XLRE | 3.93% | -11.09% | -14.68% | -7.50% |
| Technology | XLK | 4.11% | -12.43% | -25.77% | -40.28% |
| Utilities | XLU | 2.12% | -19.84% | -19.94% | -6.50% |
| Aerospace & Defense | XAR | 2.99% | -16.41% | -22.96% | -26.00% |
| Biotech | XBI | -2.30% | -13.60% | -33.33% | -10.70% |
| Homebuilder | XHB | 4.02% | -11.62% | -43.73% | -52.55% |
| Retail | XRT | 5.20% | -12.04% | -26.44% | -26.00% |
Does EXACT Sciences outperform its market, is EXAS a Sector Leader?
No, over the last 12 months EXACT Sciences (EXAS) made -2.54%, while its related Sector, the SPDR S&P Biotech (XBI) made 8.16%.
Over the last 3 months EXAS made -3.09%, while XBI made 2.28%.
No, over the last 12 months EXACT Sciences (EXAS) made -2.54%, while its related Sector, the SPDR S&P Biotech (XBI) made 8.16%.
Over the last 3 months EXAS made -3.09%, while XBI made 2.28%.
| Period | EXAS | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -14.76% | -1.16% | -1.56% |
| 3 Months | -3.09% | 2.28% | 3.75% |
| 12 Months | -2.54% | 8.16% | 27.12% |